SIMTEK CORP
8-K, 1996-12-27
SEMICONDUCTORS & RELATED DEVICES
Previous: PRINCOR HIGH YIELD FUND INC, NSAR-B, 1996-12-27
Next: OPPENHEIMER QUEST FOR VALUE FUNDS, NSAR-B, 1996-12-27



                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM 8-K


               Current Report Pursuant to Section 13 or 15 (d) of
                           The Securities Act of 1934


       Date of Report (Date of earliest event reported) December 23, 1996





                               SIMTEK CORPORATION
             (Exact name of registrant as specified in its charter)




Colorado                             0-19027                     84-1057605
- --------------------------------------------------------------------------------
(State or other                    (Commission                (I.R.S. Employer
jurisdiction                       File Number)              Identification No.)
of incorporation)



                          1465 Kelly Johnson Boulevard
                        Colorado Springs, Colorado 80920

                                 (719) 531-9444





<PAGE>


Item 5: Other Information:

         The following sets forth the Registrant's Third Quarter 1996 Interim
Report which has been mailed to its shareholders:

- --------------------------------------------------------------------------------
                                                                December 5, 1996

To Our Shareholders:

This  report  covers  the  third  quarter  and the  first  nine  months of 1996.
Shareholders who desire further disclosure information may request the following
reports from the Securities and Exchange  Commission or from Simtek Corporation:
Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q.

In the third quarter 1996,  the Company  continued to see an increase in its 0.8
micron product availability from Zentrum  Mikroelektronik  Dresden GmbH ("ZMD").
The sales of the 0.8  micron  product  accounted  for  approximately  50% of the
Company's   revenue  in  the  third  quarter  1996.  This  increase  in  product
availability along with shipments of the Company's 1.2 micron product,  obtained
from Chartered Semiconductor  Manufacturing Plc. of Singapore ("CSM"), accounted
for the Company  having a positive gross margin of $614,111 in the third quarter
1996 and a  positive  gross  margin  of  $1,315,309  for the nine  months  ended
September  30, 1996 as compared to negative  gross  margins of $108,180  for the
third quarter of 1995 and $315,399 for the nine months ended September 30, 1995.
Management of the Company believes that if product  availability  continues from
ZMD and the  current  yields on the 1.2  micron  process  at CSM  continue,  the
Company will continue to operate at a positive gross margin.

Simtek  recorded  a net profit of  $50,438  based on product  sales in the third
quarter of 1996. This net profit compared to a net loss of $690,733 for the same
period in 1995. The profit  generated was the result of a continued  increase in
customer acceptance,  product  availability,  better gross margins and decreased
operating expenses.

The increase in customer  acceptance  and product  availability  accounted for a
313%  increase in net products  sales for the third  quarter 1996 as compared to
the same period in 1995.  The  increase in net product  sales for the nine month
period was 173% as compared with the same period in 1995. The product revenue of
$3,519,718 for the first nine months of 1996 was  approximately 70% greater than
the total product revenue for all of 1995.

Better cost  controls and  decreased  headcount  enabled  Simtek to decrease its
operating  expenses by 22% in the first nine months of 1996 over the same period
in 1995.

In the third  quarter  1996,  the Company  received no monies from ZMD under the
Cooperation  Agreement it entered into in September  1995.  ZMD has the right to


<PAGE>

convert all financing paid in 1996 into shares of Simtek's  Common Stock, at the
average  share price of the quarter  that the monies were paid.  However,  ZMD's
total equity may not exceed 30% without approval of Simtek's Board of Directors.

The Company's  ability to maintain  profitability  will depend  primarily on its
ability to continue reducing  manufacturing costs and increase net product sales
by increasing the  availability of existing  products and by the introduction of
new products.  The Company believes that the Cooperation  Agreement entered into
with ZMD in September  1995 has now enabled the Company to begin  selling its 64
kilobit nvSRAM products based on 0.8 micron technology and that it will continue
to in the future.  The Company also  believes  that the joint task force created
with ZMD will expedite the introduction and production of its 256 kilobit nvSRAM
products based on 0.8 micron technology.

However, the Company may require additional capital in the first quarter 1997 to
fund  production and marketing of its 0.8 micron 256 kilobit nvSRAM products and
the development of other new products. The Company does not have any commitments
for such additional capital as of the date of this report.

The following  Statements of Operations compare the three months and nine months
ended  September 30, 1996 with September 30, 1995 and the Balance Sheets compare
September 30, 1996 with December 31, 1995.

In closing,  we are pleased with the progress  that Simtek has continued to make
during the third  quarter 1996 in all areas of the Company's  operations.  We at
Simtek appreciate your continued support.

Sincerely,

/s/ Richard L. Petritz

RICHARD L. PETRITZ
Chairman and CEO

<PAGE>

================================================================================
Balance Sheets                                                                
================================================================================

                                            September 30,       December 31,
                                                 1996               1995
                                            -------------     --------------
ASSETS
Current Assets:
    Cash .................................   $  480,569         $  311,872
    Accounts receivable - trade, net .....      669,319            210,047
    Accounts receivable - other ..........       32,878             11,072
    Inventory, net .......................      399,959            228,251
    Prepaid expenses and other assets ....       24,030             19,289
                                             ----------         ----------
         Total Current Assets ............    1,606,755            780,531

Equipment and furniture, net .............      240,649            344,676

         Total Assets ....................   $1,847,404         $1,125,207
                                             ==========         ==========

LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities
    Accounts payable .....................   $  620,930         $  277,277
    Accrued expenses .....................      278,005            153,593
    Accrued wages ........................      206,475            161,475
    Accrued vacation payable .............       80,213             78,956
    Exchangeable notes ...................      378,551               --   
                                             ----------         ----------

         Total Current Liabilities .......    1,564,174            671,301


COMMITMENTS AND CONTINGENCIES

Shareholders' Equity:
Preferred stock, $1.00 par
    value, 2,000,000 shares
    authorized and none
    issued and outstanding
    at September 30, 1996
    and December 31, 1995 ................          --                 --
Common stock, $.01 par
    value, 40,000,000 shares
    authorized, 26,988,311 and
    26,978,311 shares issued
    and outstanding at September 30,
    1996 and December 31, 1995 ...........      269,883            269,783

Additional paid-in capital ...............   29,497,514         29,496,144

Accumulated deficit ......................  (29,484,167)       (29,312,021)
                                           ------------       ------------
Shareholders' equity .....................      283,230            453,906
                                           ------------       ------------
         Total Liabilities and
           Shareholders' Equity .......... $  1,847,404       $  1,125,207
                                           ============       ============

- --------------------------------------------------------------------------------

OTC Electronic Bulletin Board       Registrar and Transfer Agent

                                    Continental Stock Transfer and Trust Company
System Symbol:                      2 Broadway
SRAM                                New York, NY  10004


<PAGE>

<TABLE>
<CAPTION>
================================================================================
Statement of Operations                                                                           
================================================================================

                                                                                                  
                                                     Three Months Ended September 30,      Nine Months Ended September 30,    
                                                           1996           1995                   1996           1995 
                                                     --------------------------------     -------------------------------     
                                                                                                  
<S>                                                   <C>               <C>               <C>               <C>    <C>    <C>
Commission Income ...............................     $      1,810      $          0      $      8,556      $          0  
Product sales, net ..............................        1,550,000           375,150         3,519,718         1,301,433
                                                      ------------      ------------      ------------      ------------

    Total Income ................................        1,551,810           375,150         3,528,274         1,301,433
Cost of product sales ...........................          935,889           483,330         2,204,409         1,616,832
                                                      ------------      ------------      ------------      ------------

    Gross Margin ................................          614,111          (108,180)        1,315,309          (315,399)

Operating Expenses
    Design, research and development ............          251,364           324,560           726,238         1,067,052
    Administrative ..............................          160,491           128,434           364,026           450,404
    Marketing ...................................          156,519           133,429           420,723           416,667
                                                      ------------      ------------      ------------      ------------
      Total operating expenses ..................          568,374           586,423         1,510,987         1,934,123
                                                      ------------      ------------      ------------      ------------
      Profit (loss) from operations .............           47,547          (694,603)         (187,122)       (2,249,522)

Other Income (Expense):

    Royalty income ..............................                0                 0                 0           600,000
    Interest income .............................            5,232             4,038            11,756            21,491
    Other income (expense), net .................           (2,341)             (168)            3,220             5,941
                                                      ------------      ------------      ------------      ------------
      Total other income (expense) ..............            2,891             3,870            14,976           627,432
                                                      ------------      ------------      ------------      ------------

Net profit (loss) ...............................     $     50,438      $   (690,733)     $   (172,146)     $ (1,622,090)
                                                      ============      ============      ============      ============

Net loss per common share .......................     $          *      $      (0.03)     $      (0.01)     $  (0.08)
                                                      ============      ============      ============      ============
Weighed average number
    of shares outstanding .......................       26,980,464        21,396,468        26,980,464        21,396,468
                                                      ============      ============      ============      ============

                                                                                                  
                                                                                                  
* Less than one cent per share                                                                    
</TABLE>


- --------------------------------------------------------------------------------
Directors and Officers
- --------------------------------------------------------------------------------

Dr. Richard L. Petritz                      Dr. Kurt Garbrecht, Director
Chairman of the Board & CEO                 Zentrum Mikroelektronik Dresden GmbH
       
Mr. Sheldon A. Taylor, Director             Dr. Klaus Wiemer, Director

Dr. Robert Keeley, Director                 Mr. Detlef Golla, Director
University of Colorado, Colorado Springs    Zentrum Mikroelektronik Dresden GmbH

- --------------------------------------------------------------------------------

Home Page:                                         E-Mail

    http://www.csn.net/simtek                      [email protected] 

<PAGE>


                                    SIGNATURE

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned and hereunto duly authorized.

                                         SIMTEK CORPORATION


                                            /s/ Richard L. Petritz
December 23, 1996                        By:___________________________________
                                              RICHARD L. PETRITZ
                                              Chief Execuitve Officer and Chief
                                              Financial Officer (acting)


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission